Isracann Biosciences Inc. (C:IPOT)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Apr 06, 2023 11:34 am ET

CSE Bulletin: Suspensions (IPOT, TCAN)

Toronto, Ontario--(Newsfile Corp. - Le 6 avril/April 2023) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.

Apr 06, 2023 09:39 am ET

IIROC Trading Halt - IPOT

VANCOUVER, BC, April 6, 2023 /CNW/ - The following issues have been halted by IIROC:

Oct 13, 2022 08:30 am ET

Isracann Biosciences Provides Bi-Weekly Default Status Report

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that further to its news release dated September 29, 2022 (the “Default Announcement”), the Company’s principal regulator, the British Columbia Securities...

Sep 29, 2022 06:25 pm ET

Isracann Biosciences Announces Delay in Filing Annual Financial Statements

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that the filing of its audited annual financial statements for the year ended May 31, 2022, including the related management discussion and analysis, and...

Sep 28, 2022 09:00 am ET

Isracann Bioscience Facilitated Genetics Arrive in Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that previously shipped...

Sep 14, 2022 08:30 am ET

Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”), a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor, is pleased to announce it has facilitated...

Sep 01, 2022 09:00 am ET

Praesidio signs distribution agreement with Pure Integrative Pharmacy

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, is please to announce that it has signed a...

Aug 23, 2022 09:00 am ET

Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board

Aug 03, 2022 09:00 am ET

Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement. The Company issued 4,679,600 units (the...

May 19, 2022 08:30 am ET

Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health medicine division in Canada and holdings in Israel, is pleased to announce that its wholly owned subsidiary...

Apr 15, 2022 08:30 am ET

Isracann Biosciences Renews Leadership to Meet Changing Demands

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that further to its acquisition of Praesidio Health Inc. as a natural health medicine division, the Company has elected to expand its...

Apr 13, 2022 08:30 am ET

Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it has closed its acquisition of Praesidio Health Inc....

Mar 28, 2022 08:30 am ET

Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a definitive agreement (the “Agreement”) dated March...

Feb 24, 2022 04:09 pm ET

UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on researching and developing innovative health solutions in conjunction with its advanced stage activities aimed at...

Feb 23, 2022 08:30 am ET

Isracann Signs LOI to Acquire Natural Health Medicine Developer

Feb 09, 2022 08:30 am ET

Isracann Advises on Recent Activities and 2022 Outlook

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low-cost, high-quality cannabis producer/distributor is pleased to provide an update of recent...

Oct 20, 2021 09:00 am ET

Isracann Appoints Operational Expert Phil Floucault as CEO and Grants Options

Aug 31, 2021 09:00 am ET

Isracann Appoints Experienced Farm Manager and Updates Israeli Cannabis Operations

Apr 21, 2021 09:00 am ET

Isracann Receives Foreign Owners License and Updates Israeli Cannabis Operations

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce it has been granted a...

Mar 18, 2021 09:00 am ET

Isracann Applauds Expanded Cannabis Accessibility

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”), an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor, is extremely pleased by recent reports and...

Mar 03, 2021 09:00 am ET

Isracann Signs Cannabis Importation LOI with Major Israeli Manufacturer

Feb 25, 2021 09:00 am ET

Isracann Prepares for Recreational Cannabis Opportunity in Israel

Feb 16, 2021 09:00 am ET

Isracann Completes Phase One Construction at Cannabis Facility in Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to announce its flagship Hefer Valley-based...

Feb 02, 2021 09:00 am ET

Isracann Prepares to Import Canadian Cannabis into Israel and Europe

Jan 19, 2021 09:00 am ET

Isracann Well Positioned for Israel’s Cannabis Sector Growth in 2021

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to provide a year end summary of activities...

Jan 11, 2021 03:07 pm ET

Isracann Announces Launch of Early Warrant Exercise Incentive Program and Repricing

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer announces it has implemented a warrant exercise incentive...

Oct 14, 2020 09:00 am ET

Isracann Welcomes International Cannabis Exports in Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to announce that the government of Israel has...

Sep 01, 2020 09:00 am ET

Isracann Updates Cannabis Farm Developments and Advises Processing Facility Expansion Underway

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer today provides a corporate review and update of its...

Aug 25, 2020 07:30 am ET

How to Capitalize on Europe's Cannabis Shortage -- CFN Media

Whitefish, Montana--(Newsfile Corp. - August 25, 2020) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries announces an article discussing Europe's cannabis shortage, and how Isracann Biosciences, Inc. (CSE: IPOT) (OTC Pink: ISCNF) stands to benefit from Israel's recent decision to permit medical cannabis exports to the European market.

Aug 12, 2020 08:00 am ET

Israel Steps Closer to Cannabis Legalization

Whitefish, Montana--(Newsfile Corp. - August 12, 2020) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries announces an article discussing Israeli cannabis legalization, and Israel's only publicly-traded cannabis pure-play, Isracann Biosciences, Inc. (CSE: IPOT) (OTC Pink: ISCNF).

Jul 02, 2020 08:30 am ET

Three Ex-U.S. and Canada Cannabis Stocks to Consider for Your Portfolio -- CFN Media

Whitefish, Montana--(Newsfile Corp. - July 2, 2020) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announces an article discussing three cannabis companies outside of North America to consider for your portfolio.

Jun 25, 2020 08:00 am ET

Cannabis Demand Remains Healthy Despite COVID-19 Challenges -- CFN Media

Whitefish, Montana--(Newsfile Corp. - June 25, 2020) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announces an article discussing the increasing demand for cannabis and Israel's only publicly-traded cannabis pure-play, Isracann Biosciences, Inc. (CSE: IPOT) (OTC Pink: ISCNF).

Jun 11, 2020 09:05 am ET

Isracann Endorses Israeli Cannabis Decriminalization Actions

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to advise upon and firmly support recent news...

Jun 04, 2020 12:05 am ET

Isracann Prepares for Israel’s New Cannabis Export Permit Process and Announces New COO

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased by the recent government approval permitting...

Jun 01, 2020 08:00 am ET

Israel Gives Final Go-Ahead for Cannabis Exports: Here's Who Could Profit -- CFN Media

Santa Monica, California--(Newsfile Corp. - June 1, 2020) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announces an article discussing Israel's recent approval for cannabis exports and how companies like Isracann Biosciences, Inc. (CSE: IPOT) (OTC Pink: ISCNF) are well-positioned to profit.

May 20, 2020 07:30 am ET

How to Invest in a Global Cannabis Portfolio - CFN Media

Seattle, Washington--(Newsfile Corp. - May 20, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the global cannabis, CBD, and psychedelics industries announces the publication of an article discussing Isracann Biosciences, Inc. and its unique position in the global cannabis market.

May 14, 2020 12:05 am ET

Isracann Increases Focus on EU Demand

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is accelerating efforts to service an anticipated...

May 07, 2020 08:45 am ET

Isracann JV in Israel Advances Towards Cannabis Production

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased...

Apr 08, 2020 12:05 am ET

Isracann Closes JV Cannabis Farm Production Agreement With 3-Year Offtake in Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased...

Mar 27, 2020 07:30 am ET

Israel Begins Cannabis Exports to Meet Unmet Medical Needs -- CFN Media

Seattle, Washington--(Newsfile Corp. - March 27, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the legalized North American cannabis industry announces publication of an article discussing how Israel has shipped the first cannabis export to the UK, marking a new era in Israeli cannabis.

Mar 24, 2020 12:05 am ET

Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased...

Feb 27, 2020 09:00 am ET

Isracann Completes Executive Site and Prospect Visit in Israel

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to provide a...

Jan 09, 2020 12:05 am ET

Isracann Receives Project Characterization Report and Engages EU GMP Consultancy

Jan 02, 2020 09:00 am ET

Isracann Enters MOU for European Distribution

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to announce...

Jan 02, 2020 12:05 am ET

Isracann Enters MOU for European Distribution

Dec 30, 2019 09:00 am ET

Isracann Provides Year End Review

Dec 30, 2019 12:05 am ET

Isracann Provides Year End Review

Dec 23, 2019 10:34 am ET

Investors Opening Eyes to Opportunity in Israel Cannabis, Including Exclusive CEO Video Interview Part #2 -- CFN Media

Seattle, Washington--(Newsfile Corp. - December 23, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT) (OTC: ISCNF).

Dec 17, 2019 07:30 am ET

Canadian Cannabis Success Being Replayed in Israel Right Now -- CFN Media

Seattle, Washington--(Newsfile Corp. - December 17, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT) (OTC: ISCNF).

Dec 17, 2019 12:05 am ET

Isracann Advances New Partnership with Late Stage Cannabis Farm in Israel

Dec 10, 2019 07:20 am ET

Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up -- CFN Media

Seattle, Washington--(Newsfile Corp. - December 10, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT) (OTC: ISCNF).

Dec 05, 2019 12:05 am ET

Isracann Advances Cannabis Project Characterization in Israel

Nov 28, 2019 12:05 am ET

Isracann Biosciences Receives Land Use & Facility Approvals from Israeli Land Authority and Amends Warrants

Nov 21, 2019 12:01 am ET

Isracann Biosciences Submits Cannabis Facility Plans to Israeli Land Authority

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that...

Nov 20, 2019 07:15 am ET

Israel Writing Playbook to Become Cannabis Gateway to Europe -- CFN Media

Seattle, Washington--(Newsfile Corp. - November 20, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences Inc. (CSE: IPOT) (OTC Pink: ATLED).

Nov 15, 2019 09:00 am ET

Isracann Biosciences Announces OTC Trading Symbol Change to “ISCNF”, Effective November 15, 2019

Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both Israeli and European export sales, is...

Nov 14, 2019 12:01 am ET

Isracann Biosciences Hires Expert Consultancy LinC to Steer Israeli Cannabis Project

Nov 13, 2019 07:35 am ET

Top Israeli Cannabis Companies Targeting European Markets

Seattle, Washington--(Newsfile Corp. - November 13, 2019) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences Inc. (CSE: IPOT) (OTC: ATLED).

Nov 06, 2019 08:00 am ET

Cannabis News and Stocks on the Move: Exclusive Podcast Interview with Darryl Jones, CEO and President of Isracann Biosciences Inc.

Delta, British Columbia and Kelowna, British Columbia--(Newsfile Corp. - November 6, 2019) - https://www.investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM ; cannabis news and stocks to watch plus insight from thought leaders and experts.

Nov 05, 2019 01:33 pm ET

Canadian Securities Exchange Attracts First Israeli Company Listings

IM Cannabis becomes third Israeli cannabis listing in past six weeks

Nov 05, 2019 12:01 am ET

Isracann Biosciences Advances Architectural and Security Plans for Israeli Project

Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and...

Oct 31, 2019 07:30 am ET

Snoop Dogg Down With Israeli Cannabis Company, Highlights Investment in the Country -- CFN Media

Seattle, Washington--(Newsfile Corp. - October 31, 2019) - CFN Media, the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT).

Oct 29, 2019 07:30 am ET

It's Always Sunny in Israel; How Isracann Biosciences Inc. is Seizing the Cannabis Opportunity

Cannabis Global Expansion from Israel to the EU

Oct 28, 2019 12:01 am ET

Isracann Biosciences Launches Phase One Facility Development Program in Israel

Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel....

Oct 25, 2019 07:00 am ET

Leading Israeli Cannabis Company Goes Public -- CFN Media

Seattle, Washington--(Newsfile Corp. - October 25, 2019) - CFN Media, the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT).

Oct 21, 2019 09:00 am ET

CSE New Listing - Isracann Biosciences Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - October 21, 2019) - Isracann Biosciences Inc. (CSE: IPOT) is one of the latest new listings on the Canadian Securities Exchange, trading under the symbol "IPOT", following the reverse take-over of Atlas Blockchain Group. Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces.

Oct 16, 2019 10:08 pm ET

Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements

Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company...

Jun 12, 2019 08:12 am ET

Israel Builds Dominant Position in the Global Medical Cannabis Industry -- CFN Media

Seattle, Washington--(Newsfile Corp. - June 12, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences Inc. [CSE: IPOT (Pending)]. The company aims to become Israel's first pure-play cannabis firm listed in Canada with a four-pronged focus on cultivation, distribution, products and manufacturing, and R&D genetics.

May 28, 2019 07:30 am ET

Isracann Raises C$10.1 Million in Bid to Supply European Market with Israeli Cannabis -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 28, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences Inc. (CSE: IPOT - pending).

Ad blocking detected

Isracann Biosciences Inc. (C:IPOT)

Business Focus: Alternative Medicine